Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot Topic: TB Drug Development (Guest Editor: Courtney C. Aldrich)] promotion: free to download

Volume:12   Issue: 7
Pp: 671-671
Courtney C. Aldrich
DOI: 10.2174/156802612799984553
Published on: 18 March, 2012

Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds open access plus

Volume:12   Issue: 7
Pp: 672-693
Pan Pan and Peter J. Tonge
DOI: 10.2174/156802612799984535
Published on: 18 March, 2012

Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Volume:12   Issue: 7
Pp: 694-705
S. Van Calenbergh, S. Pochet and H. Munier-Lehmann
DOI: 10.2174/156802612799984580
Published on: 18 March, 2012

Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis

Volume:12   Issue: 7
Pp: 729-734
Annamaria Lilienkampf, Marco Pieroni, Scott G. Franzblau, William R. Bishai and Alan P. Kozikowski
DOI: 10.2174/156802612799984544
Published on: 18 March, 2012

Natural Products as Leads for Tuberculosis Drug Development open access plus

Volume:12   Issue: 7
Pp: 735-765
Christine E. Salomon and Lori E. Schmidt
DOI: 10.2174/156802612799984526
Published on: 18 March, 2012

Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets

Volume:12   Issue: 7
Pp: 766-796
Benjamin P. Duckworth, Kathryn M. Nelson and Courtney C. Aldrich
DOI: 10.2174/156802612799984571
Published on: 18 March, 2012


Volume:12   Issue: 7
Pp: 797-797
Emilio Jirillo
DOI: 10.2174/156802612799984562
Published on: 18 March, 2012